This inventor holds 30 USPTO granted patents and 13 published patent applications and 12 EPO patents, primarily in Electrophysiological Mapping. Top assignees: Ablacon Inc., Sophono, Inc., Helen of Troy Limited. Active years: 2015-2026.
Company Filing History:
12 out of 12 
6 out of 10 
4 out of 835 
Years Active: 2015-2026
Areas of Expertise:
Title: **Innovative Contributions of Peter Ruppersberg to Cardiac Rhythm Disorder Detection**
Introduction
Peter Ruppersberg, an accomplished inventor based in Blonay, Switzerland, has made significant strides in the field of cardiac health through his groundbreaking innovations. With a portfolio of 26 patents, he is recognized for developing advanced systems and methods aimed at detecting and analyzing cardiac rhythm disorders.
Latest Patents
Ruppersberg’s latest patents demonstrate his commitment to enhancing cardiac care. His patent titled "Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart using improved electrographic flow (EGF) methods" reveals various systems and devices designed to estimate action potential wave propagation in the heart. This innovative technology allows for the localization of cardiac rhythm disorder sources through the use of intracardiac electrodes and a modified multi-frame Horn-Schunck algorithm, ultimately providing a spatial map on a display for user reference.
Another significant patent by Ruppersberg focuses on similar technologies under the title "Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart." This patent outlines systems that acquire, normalize, and process electrogram signals from within the heart. By generating two-dimensional spatial maps and corresponding three-dimensional electrogram surfaces, his methods lead to the creation of velocity vector maps that pinpoint the origins of cardiac rhythm disorders, potentially identifying active rotors in the myocardium and atrium.
Career Highlights
Throughout his career, Peter Ruppersberg has held positions at notable companies in the medical technology sector, including Ablacon Inc. and Sophono, Inc. His work in these organizations has enabled him to focus on innovative cardiac solutions, applying his extensive knowledge and skills to improve patient outcomes.
Collaborations
Ruppersberg has collaborated with prominent professionals in his field, including Markus C. Haller and Todd C. Wyant. These partnerships have fostered an environment of collaborative innovation, allowing for the development and refinement of technologies aimed at cardiac health.
Conclusion
Peter Ruppersberg's contributions to the field of cardiac rhythm disorder detection are significant and ongoing. Through his numerous patents and collaborations, he continues to drive forward innovations that promise to enhance diagnostics and treatment for patients suffering from cardiac rhythm disorders, solidifying his place as a leading inventor in the medical technology domain.